• 1
    Aronson J, Harrison BH, Stewart CL, Harp JH Jr 1989 The histology of distraction osteogenesis using different external fixators. Clin Orthop 241:106116.
  • 2
    Ilizarov GA 1989 The tension-stress effect on the genesis and growth of tissues. Part I. The influence of stability of fixation and soft-tissue preservation. Clin Orthop 238:249281.
  • 3
    Schenk RK, Gächter A 1994 Histology of Distraction Osteogenesis. In: BrightonC, FriedlaenderG, LaneJM (eds.). Bone Formation and Repair. American Academy of Orthopedic Surgeons, Rosemont, IL, USA, pp. 387394.
  • 4
    Sato M, Yasui N, Nakase T, Kawahata H, Sugimoto M, Hirota S, Kitamura Y, Nomura S, Ochi T 1998 Expression of bone matrix proteins mRNA during distraction osteogenesis. J Bone Miner Res 13:12211231.
  • 5
    Vauhkonen M, Peltonen J, Karaharju E, Aalto K, Alitalo I 1990 Collagen synthesis and mineralization in the early phase of distraction bone healing. Bone Miner 10:171181.
  • 6
    Bolander ME 1994 Regulation of fracture repair and synthesis of matrix macromolecules. In: BrightonC, FriedlaenderG, LaneJM (eds.) Bone Formation and Repair. American Academy of Orthopedic Surgeons, Rosemont, IL, USA, pp. 185196.
  • 7
    Cornell CN, Lane JM 1992 Newest factors in fracture healing. Clin Orthop 277:297311.
  • 8
    Einhorn TA, Simon G, Devlin VJ, Warman J, Sidhu SP, Vigorita VJ 1990 The osteogenic response to distant skeletal injury. J Bone Joint Surg Am 72:13741378.
  • 9
    Einhorn TA 1994 Enhancement of fracture healing by molecular or physical means: An overview. In: BrightonC, FriedlaenderG, LaneJM (eds.) Bone Formation and Repair. American Academy of Orthopedic Surgeons, Rosemont, IL, USA, pp. 223238.
  • 10
    Mohan S, Baylink DJ 1991 Bone growth factors. Clin Orthop 263:3048.
  • 11
    Mundy GR 1993 Factors which stimulate bone growth in vivo. Growth Regul 3:124128.
  • 12
    Mundy GR 1995 Local control of bone formation by osteoblasts. Clin Orthop 313:1926.
  • 13
    Matrisian LM 1990 Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121125.
  • 14
    Bord S, Horner A, Hembry RM, Compston JE 1998 Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: Potential roles in skeletal development. Bone 23:712.
  • 15
    Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z 1998 MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411422.
  • 16
    Witty JP, Foster SA, Stricklin GP, Matrisian LM, Stern PH 1996 Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B. J Bone Miner Res 11:7278.
  • 17
    Yamagiwa H, Tokunaga K, Hayami T, Hatano H, Uchida M, Endo N, Takahashi HE 1999 Expression of metalloproteinase-13 (collagenase-3) is induced during fracture healing in mice. Bone 25:197203.
  • 18
    Bidner SM, Rubins IM, Desjardins JV, Zukor DJ, Goltzman D 1990 Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg Am 72:11441149.
  • 19
    Gazit D, Karmish M, Holzman L, Bab I 1990 Regenerating marrow induces systemic increase in osteo- and chondrogenesis. Endocrinology 126:26072613.
  • 20
    Mueller M, Schilling T, Minne HW, Ziegler R 1991 A systemic acceleratory phenomenon (SAP) accompanies the regional acceleratory phenomenon (RAP) during healing of a bone defect in the rat. J Bone Miner Res 6:401410.
  • 21
    Trippel SB 1994 Biologic regulation of bone growth. In: BrightonCT, FriedlaenderG, LaneJM (eds.) Bone Formation and Repair. American Academy of Orthopedic Surgeons, Rosemont, IL, USA, pp. 3960.
  • 22
    Raschke MJ, Bail H, Windhagen HJ, Kolbeck SF, Weiler A, Raun K, Kappelgard A, Skiaerbaek C, Haas NP 1999 Recombinant growth hormone accelerates bone regenerate consolidation in distraction osteogenesis. Bone 24:8188.
  • 23
    Saggese G, Baroncelli GI, Bertelloni S, Barsanti S 1996 The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 81:30773083.
  • 24
    Weusten A, Lochmueller E-M, Cindik E, Renner-Mueller I, Tysarczyk-Niemeyer G, Wolf E, Eckstein F 1999 Femoral bone mass, size and density in male and female growth hormone transgenic mice. Transgenics 3:4350.
  • 25
    Baumgart R, Betz A, Schweiberer L 1997 A fully implantable motorized intramedullary nail for limb lengthening and bone transport. Clin Orthop 343:135141.
  • 26
    Anker SD, Volterrani M, Pflaum CD, Strasburger CJ, Osterziel KJ, Doehner W, Ranke MB, Poole-Wilson PA, Giustina A, Dietz R, Coats AJ 2001 Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone J Am Coll Cardiol 38:443452.
  • 27
    Baumann G 1996 Growth hormone-binding proteins—an overview. Acta Paediatr Suppl 417:9597.
  • 28
    Buckley MJ, Banes AJ, Levin LG, Sumpio BE, Sato M, Jordan R, Gilbert J, Link GW, Tran Son Tay R 1988 Osteoblasts increase their rate of division and align in response to cyclic, mechanical tension in vitro. Bone Miner 4:225236.
  • 29
    Klein-Nulend J, Roelofsen J, Sterck JG, Semeins CM, Burger EH 1995 Mechanical loading stimulates the release of transforming growth factor-beta activity by cultured mouse calvariae and periosteal cells. J Cell Physiol 163:115119.
  • 30
    Neidlinger-Wilke C, Wilke HJ, Claes L 1994 Cyclic stretching of human osteoblasts affects proliferation and metabolism: A new experimental method and its application. J Orthop Res 12:7078.
  • 31
    Roelofsen J, Klein-Nulend J, Burger EH 1995 Mechanical stimulation by intermittent hydrostatic compression promotes bone-specific gene expression in vitro. J Biomech 28:14931503.
  • 32
    Eingartner C, Coerper S, Fritz J, Gaissmaier C, Koveker G, Weise K 1999 Growth factors in distraction osteogenesis. Immuno-histological pattern of TGF-beta1 and IGF-I in human callus induced by distraction osteogenesis. International Orthopaedics (SICOT) 23:253259.
  • 33
    Holbein O, Neidlinger-Wilke C, Suger G, Kinzl L, Claes L 1995 Ilizarov callus distraction produces systemic bone cell mitogens. J Orthop Res 13:629638.
  • 34
    Lammens J, Liu Z, Aerssens J, Dequeker J, Fabry G 1998 Distraction bone healing versus osteotomy healing: A comparative biochemical analysis. J Bone Miner Res 13:279286.
  • 35
    Casser HR, Zilkens KW, Forst R, Bruggemann A 1990 Influence of bone and soft-tissue operations on serum concentrations of growth hormone, somatomedin C and alkaline phosphatase. Arch Orthop Trauma Surg 109:272276.
  • 36
    Stein GS, Lian JB 1993 Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424442.
  • 37
    Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M 1986 Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin- Sepharose. J Biol Chem 261:1266512674.
  • 38
    Cuttler L 1996 The regulation of growth hormone secretion. Endocrinol Metab Clin North Am 25:541571.
  • 39
    Cuthbertson DP 1978 Post-traumatic metabolism: A multidisciplinary challenge. Surg Clin North Am 58:10451054.
  • 40
    Lal SK, Jakob KC, Nagi ON, Annamalai AL, Nair CR 1976 Variations of some plasma components after closed fractures. J Trauma 16:206211.
  • 41
    Aronson J 1994 Experimental assessment of bone regenerate quality during distraction osteogenesis. In: BrightonCT, FriedlaenderG, LaneJM (eds.) Bone Formation and Repair. American Academy of Orthopedic Surgeons, Rosemont, IL, USA, pp. 441463.
  • 42
    Sang QX 1998 Complex role of matrix metalloproteinases in angiogenesis. Cell Res 8:171177.
  • 43
    Brem H, Folkman J 1994 Angiogenesis and basic fibroblast growth factor during wound healing. In: BrightonCT, Friedlaender, G, LaneJ M (eds.) Bone Formation and Repair. American Academy of Orthopaedic Surgeons, Rosemont, IL, USA, pp. 213222.
  • 44
    Pickering JG, Ford CM, Tang B, Chow LH 1997 Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. Arterioscler Thromb Vasc Biol 17:475482.